Viiv Healthcare Company drugs

14 results
  • apretude - cabotegravir

    (Cabotegravir)
    Viiv Healthcare Company
    Apretude is used for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection in adults and adolescents weighing at least 35 kg who are at risk. A negative HIV-1 test is required before starting.
  • cabenuva - cabotegravir and rilpivirine

    (Cabotegravir And Rilpivirine)
    Viiv Healthcare Company
    Cabenuva is a complete HIV-1 treatment regimen for adults and adolescents 12+ weighing at least 35 kg who are virologically suppressed on a stable antiretroviral regimen with no treatment failure history or resistance to cabotegravir or rilpivirine.
  • dovato - dolutegravir sodium and lamivudine tablet, film coated

    (Dolutegravir Sodium And Lamivudine)
    Viiv Healthcare Company
    DOVATO is a complete regimen for HIV-1 infection in adults and adolescents (12+ years, ≥25 kg) with no antiretroviral treatment history, or to replace a stable regimen in those virologically suppressed with no treatment failure or resistance to DOVATO's components.
  • juluca - dolutegravir sodium and rilpivirine hydrochloride tablet, film coated

    (Dolutegravir Sodium And Rilpivirine Hydrochloride)
    Viiv Healthcare Company
    Juluca is a complete antiretroviral regimen for HIV-1 infection in adults. It replaces current therapy in patients who are virologically suppressed (HIV-1 RNA <50 copies/mL) on a stable regimen for at least 6 months with no prior treatment failure or resistance to its components.
  • rukobia - fostemsavir tromethamine tablet, film coated, extended release

    (Fostemsavir Tromethamine)
    Viiv Healthcare Company
    Rukobia, used with other antiretrovirals, treats HIV-1 in heavily treatment-experienced adults with multidrug-resistant HIV-1 who are failing their current regimen due to resistance, intolerance, or safety concerns.